Clinical management of psoriatic arthritis and axial spondyloarthritis
Innovation in spondyloarthritides therapy offers individualised management of the heterogeneous manifestations of this condition. Biologic disease-modifying therapies rapidly and significantly improve QoL and health outcomes
Learning objectives
You will learn:
- Aspects of the pathogenesis of psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA)
- Principles of clinical assessment of PsA and axSpA activity
- Safety and efficacy data for newer treatment options and guideline-recommended approaches to the management of PsA and axSpA.
To access this module, please register or login: